The percentage of patients aged 18 and older with a diagnosis of atherosclerotic disease whose most recent LDL-C value is greater than 100 mg/dL and who are taking a lipid lowering agent
Measure Specs
General Information
Numerator
Patients with a current fill for a lipid lowering agent
Denominator
Patients with a diagnosis of atherosclerotic disease and whose most recent LDL-C is greater than 100 mg/dL.
Exclusions
General exclusions:
1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months
2. Patients who have been in a skilled nursing facility in the last 3 months
3. Patients who are terminally ill or in Hospice
4. Patient or provider feedback indicating allergy, intolerance or other contraindication to lipid lowering therapy anytime in the past
Public Comments